{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T13:45:40Z","timestamp":1776951940299,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009326","name":"CRS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jss.2018.09.032","type":"journal-article","created":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T10:43:50Z","timestamp":1539341030000},"page":"240-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Trends in Outcomes After Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy"],"prefix":"10.1016","volume":"234","author":[{"given":"Faiz","family":"Gani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison M.","family":"Conca-Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda","family":"Nettles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nita","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian M.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2018.09.032_bib1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3322\/caac.21277","article-title":"Looking up: recent advances in understanding and treating peritoneal carcinomatosis","volume":"65","author":"Lambert","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jss.2018.09.032_bib2","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1200\/JCO.2006.07.1142","article-title":"Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma","volume":"24","author":"Yan","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2018.09.032_bib3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1245\/s10434-006-9182-x","article-title":"A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei","volume":"14","author":"Yan","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2018.09.032_bib4","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1046\/j.1365-2168.2002.02274.x","article-title":"Peritoneal carcinomatosis from colorectal cancer","volume":"89","author":"Jayne","year":"2002","journal-title":"Br J Surg"},{"key":"10.1016\/j.jss.2018.09.032_bib5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/1097-0142(19890115)63:2<364::AID-CNCR2820630228>3.0.CO;2-V","article-title":"Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors","volume":"63","author":"Chu","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2018.09.032_bib6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","article-title":"Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study","volume":"88","author":"Sadeghi","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2018.09.032_bib7","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1245\/s10434-014-3978-x","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis","volume":"22","author":"Helm","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2018.09.032_bib8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/jso.21053","article-title":"Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination","volume":"98","author":"Esquivel","year":"2008","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jss.2018.09.032_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2018.09.032_bib10","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1245\/s10434-014-4157-9","article-title":"Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study","volume":"22","author":"Spiliotis","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2018.09.032_bib11","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/cncr.22466","article-title":"Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer: a systematic review with metaanalyses","volume":"109","author":"Elit","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2018.09.032_bib12","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/SLA.0b013e3181a45d86","article-title":"Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality","volume":"249","author":"Chua","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2018.09.032_bib13","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1245\/s10434-013-3223-z","article-title":"Morbidity and mortality of cytoreduction with intraperitoneal chemotherapy: outcomes from the ACS NSQIP database","volume":"21","author":"Bartlett","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2018.09.032_bib14","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1245\/s10434-007-9701-4","article-title":"Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center","volume":"15","author":"Gusani","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2018.09.032_bib15","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/jamasurg.2013.3640","article-title":"Surgical outcomes of hyperthermic intraperitoneal chemotherapy: analysis of the american college of surgeons national surgical quality improvement program","volume":"149","author":"Jafari","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jss.2018.09.032_bib16","doi-asserted-by":"crossref","first-page":"S898","DOI":"10.1245\/s10434-015-4624-y","article-title":"Age-related morbidity and mortality with cytoreductive surgery","volume":"22","author":"Peters","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2018.09.032_bib17","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s10434-999-0790-0","article-title":"Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique","volume":"6","author":"Stephens","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2018.09.032_bib18","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/(SICI)1097-0142(19960615)77:12<2622::AID-CNCR28>3.0.CO;2-T","article-title":"Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy","volume":"77","author":"Jacquet","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2018.09.032_bib19","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jamasurg.2014.629","article-title":"Extended length of stay after surgery: complications, inefficient practice, or sick patients?","volume":"149","author":"Krell","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jss.2018.09.032_bib20","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.amjsurg.2009.07.025","article-title":"Design and statistical methodology of the national surgical quality improvement program: why is it what it is?","volume":"198","author":"Henderson","year":"2009","journal-title":"Am J Surg"},{"key":"10.1016\/j.jss.2018.09.032_bib21","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1200\/jco.2009.27.15_suppl.5524","article-title":"Systematic review of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian peritoneal carcinomatosis: a more efficacious way of delivering intraperitoneal chemotherapy","volume":"27","author":"Chua","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2018.09.032_bib22","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.ejso.2008.10.006","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival","volume":"35","author":"Hagendoorn","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jss.2018.09.032_bib23","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/PPO.0b013e3181a58d56","article-title":"Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve","volume":"15","author":"Mohamed","year":"2009","journal-title":"Cancer J"},{"key":"10.1016\/j.jss.2018.09.032_bib24","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/bjs.9674","article-title":"Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei","volume":"101","author":"Kusamura","year":"2014","journal-title":"Br J Surg"},{"key":"10.1016\/j.jss.2018.09.032_bib25","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1245\/s10434-014-4111-x","article-title":"Institutional learning curve of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for peritoneal malignancies","volume":"22","author":"Polanco","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2018.09.032_bib26","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1245\/s10434-007-9406-8","article-title":"Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy--a journey to becoming a Nationally Funded Peritonectomy Center","volume":"14","author":"Yan","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2018.09.032_bib27","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/bjs.5863","article-title":"Learning curve of combined modality treatment in peritoneal surface disease","volume":"94","author":"Smeenk","year":"2007","journal-title":"Br J Surg"},{"key":"10.1016\/j.jss.2018.09.032_bib28","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1245\/s10434-015-4892-6","article-title":"Predictors of severe morbidity after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis","volume":"23","author":"Simkens","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2018.09.032_bib29","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/bjc.2014.369","article-title":"Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a systematic review","volume":"111","author":"Sloothaak","year":"2014","journal-title":"Br J Cancer"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480418306553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480418306553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T23:23:44Z","timestamp":1605223424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480418306553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":29,"alternative-id":["S0022480418306553"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2018.09.032","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in Outcomes After Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2018.09.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}